Rebecca J. Peterson

Rebecca J. Peterson

Keine laufenden Positionen mehr

Health Technology

Ursprung des Netzwerks ersten Grades von Rebecca J. Peterson

EinheitArt der EinheitIndustrie
7
Extinct Pharmaceuticals: Major 7

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Rebecca J. Peterson

UnternehmenSektorVerknüpfte PersonenHauptposition
Miscellaneous Commercial Services

Paul W. D. Chapman

Corporate Officer/Principal

Medical Specialties

Louis Villalba

Corporate Officer/Principal

CUBIST PHARMACEUTICALS INC Pharmaceuticals: Major

William Steinkrauss

Corporate Officer/Principal

CURIS, INC. Biotechnology

William Steinkrauss

Director of Finance/CFO

BRUKER CORPORATION Medical Specialties

Toni Spinazzola

Human Resources Officer

DNIB UNWIND INC Biotechnology

Arthur Tzianabos

Director/Board Member

QUANTERIX CORPORATION Medical Specialties

Paul W. D. Chapman

Chief Executive Officer

SHIRE Pharmaceuticals: Major

Arthur Tzianabos

Chief Tech/Sci/R&D Officer

Hospital/Nursing Management

Arthur Tzianabos

Director/Board Member

Medical Specialties

Paul W. D. Chapman

Corporate Officer/Principal

Boston College College/University

Arthur Tzianabos

William Steinkrauss

Undergraduate Degree

Graduate Degree

Emmanuel College (Massachusetts) College/University

Toni Spinazzola

Graduate Degree

Suffolk University College/University

Toni Spinazzola

Undergraduate Degree

Menlo College College/University

Louis Villalba

Undergraduate Degree

Providence College College/University

Theresa McNeely

Undergraduate Degree

Simmons University College/University

Theresa McNeely

Graduate Degree

University of Guelph College/University

Paul W. D. Chapman

Undergraduate Degree

University of Western Ontario College/University

Paul W. D. Chapman

Undergraduate Degree

University of Illinois College/University

John D. Eisel

Undergraduate Degree

University of New Hampshire College/University

Arthur Tzianabos

Corporate Officer/Principal

Investment Managers

Arthur Tzianabos

Private Equity Investor

Pharmaceuticals: Major

Arthur Tzianabos

Corporate Officer/Principal

Medical/Nursing Services

Paul W. D. Chapman

Corporate Officer/Principal

AKEBIA THERAPEUTICS, INC. Pharmaceuticals: Major

Theresa McNeely

Investor Relations Contact

Hospital/Nursing Management

John D. Eisel

Corporate Officer/Principal

Miscellaneous Commercial Services

Theresa McNeely

Director/Board Member

Medical Specialties

Louis Villalba

Corporate Officer/Principal

Harvard Medical School College/University

Arthur Tzianabos

Corporate Officer/Principal

Roche Austria GmbH

Paul W. D. Chapman

Corporate Officer/Principal

Biotechnology

Louis Villalba

Sales & Marketing

Medical/Nursing Services

Arthur Tzianabos

Director/Board Member

Kellogg School of Management College/University

John D. Eisel

Masters Business Admin

Spinazzola, Inc.

Toni Spinazzola

Director/Board Member

STOKE THERAPEUTICS, INC. Biotechnology

Arthur Tzianabos

Director/Board Member

AKOUOS Biotechnology

Arthur Tzianabos

Chairman

Miscellaneous Commercial Services

Louis Villalba

Director/Board Member

Miscellaneous Commercial Services

Louis Villalba

Chief Executive Officer

Information Technology Services

Louis Villalba

Chief Executive Officer

Information Technology Services

Paul W. D. Chapman

Director/Board Member

Financial Conglomerates

Louis Villalba

Director/Board Member

Myocea

Louis Villalba

Director/Board Member

Industrial Machinery

Arthur Tzianabos

Director/Board Member

Medical/Nursing Services

Paul W. D. Chapman

Chief Executive Officer

Statistik

International

Vereinigte Staaten 42
Kanada 4
Irland 2
Frankreich 2
Österreich 2

Sektoral

Health Technology 18
Consumer Services 13
Commercial Services 8
Health Services 6
Finance 3

Operativ

Corporate Officer/Principal 18
Director/Board Member 15
Undergraduate Degree 8
Chief Executive Officer 5
Public Communications Contact 4
  1. Börse
  2. Insiders
  3. Rebecca J. Peterson
  4. Unternehmensverbindungen
-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT